EUVIMEDEUVIMED entdecken
Crossref

Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease

Sasha A S Kjeldsen iD, Mikkel P Werge, Josephine Grandt iD, Michael M Richter iD, Mira Thing, Liv E Hetland, Elias B Rashu, Anne-Sofie H Jensen iD, Marie Winther-Sørensen iD, Jesper Sloth Kellemann, Jens J Holst, Anders E Junker und 4 weitere

American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.10.2024 · 327 (4) · G558-G570

DOI: 10.1152/ajpgi.00147.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.10.2024. Verfasst von Sasha A S Kjeldsen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon, Body Mass Index, Fatty Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Novo Nordisk Fonden (NNF), European Foundation for the Study of Diabetes (EFSD), Sundhed og Sygdom, Det Frie Forskningsråd (FSS, DFF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) present with increased plasma levels of glucagon (hyperglucagonemia), irrespective of body mass index (BMI) and type 2 diabetes. Therefore, MASLD and the resultant hyperglucagonemia may act as a diabetogenic risk factor. Notably, hepatic steatosis was a significant contributor to the hyperglucagonemia in MASLD, potentially unveiling a pathway for the hyperglucagonemia in some patients with type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2GlucagonBody Mass IndexFatty LiverLiver CirrhosisHumansMaleMiddle AgedFemaleObesityLiverAgedAdultAmino Acids

Stichwörter der Autor:innen

MASLDdiabetesglucagon biologyliver-alpha cell axisureagenesis

Substanzen

GlucagonAmino Acids

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark.
  • Gastro Unit, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.
  • Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Pathology, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.

ORCID-Profile: Sasha A S Kjeldsen, Josephine Grandt, Michael M Richter, Anne-Sofie H Jensen, Marie Winther-Sørensen, Nicolai J Wewer Albrechtsen

Förderung

  • Novo Nordisk Fonden (NNF)
  • European Foundation for the Study of Diabetes (EFSD)
  • Sundhed og Sygdom, Det Frie Forskningsråd (FSS, DFF)

Zitieren

APA

Kjeldsen, S. A. S., Werge, M. P., Grandt, J., Richter, M. M., Thing, M., Hetland, L. E., Rashu, E. B., Jensen, A. H., Winther-Sørensen, M., Kellemann, J. S., Holst, J. J., Junker, A. E., Serizawa, R. R., Vyberg, M., Gluud, L. L., & Wewer Albrechtsen, N. J. (2024). Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology, 327(4), G558-G570. https://doi.org/10.1152/ajpgi.00147.2024

Vancouver

Kjeldsen SAS, Werge MP, Grandt J, Richter MM, Thing M, Hetland LE, et al. Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024;327(4):G558-G570. doi:10.1152/ajpgi.00147.2024

BibTeX
@article{Kjeldsen2024,
  author = {Kjeldsen, Sasha A S and Werge, Mikkel P and Grandt, Josephine and Richter, Michael M and Thing, Mira and Hetland, Liv E and Rashu, Elias B and Jensen, Anne-Sofie H and Winther-Sørensen, Marie and Kellemann, Jesper Sloth and Holst, Jens J and Junker, Anders E and Serizawa, Reza R and Vyberg, Mogens and Gluud, Lise Lotte and Wewer Albrechtsen, Nicolai J},
  title = {Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2024},
  volume = {327},
  number = {4},
  pages = {G558--G570},
  doi = {10.1152/ajpgi.00147.2024}
}
Kostenlos starten →